Predictors of Medication-Assisted Treatment Initiation for Opioid Use Disorder in an Interdisciplinary Primary Care Model
- PMID: 31506368
- PMCID: PMC6754209
- DOI: 10.3122/jabfm.2019.05.190012
Predictors of Medication-Assisted Treatment Initiation for Opioid Use Disorder in an Interdisciplinary Primary Care Model
Abstract
Introduction: Medication-assisted treatment (MAT) for opioid use disorder (OUD) is underused in primary care. Little is known about patient demographics associated with MAT initiation, particularly among models with an interdisciplinary approach, including behavioral health integration. We hypothesize few disparities in MAT initiation by patient characteristics after implementing this model for OUD.
Methods: Electronic health record data were used to identify adults with ≥1 primary care visit in 1 of 2 study clinics in a Pacific Northwest academic health system between September 1, 2015 and August 31, 2017 (n = 23,372). Rates of documented OUD diagnosis were calculated. Multivariate logistic regression estimated odds ratios of MAT initiation, defined as ≥1 electronic health record order for buprenorphine or naltrexone, by patient covariates.
Results: Seven percent of the study sample had an OUD diagnosis. Of those patients, 32% had ≥1 MAT order. Patients with documented psychiatric diagnoses or tobacco use had higher odds of initiating MAT (odds ratio [OR] = 1.62, P = .0003; OR = 2.46, P < .0001, respectively). Uninsured, Medicaid, and Medicare patients had lower odds than those commercially insured (OR = 0.53, 0.38, and 0.31, respectively; P < .0001). Patients who were older, of a race/ethnicity other than non-Hispanic white, had documented diabetes, and had documented asthma or chronic obstructive pulmonary disease showed lower odds of initiation.
Discussion: MAT initiation varied by patient characteristics, including disparities by insurance coverage and race/ethnicity. The addition of behavioral health did not eliminate disparities in care, but higher odds of initiation among those with a documented psychiatric diagnosis may suggest this model reaches some vulnerable populations. Additional research is needed to further examine these findings.
Keywords: Addiction Medicine; Health Care Disparities; Mental Health; Northwestern United States; Opioid-Related Disorders; Primary Health Care.
© Copyright 2019 by the American Board of Family Medicine.
Conflict of interest statement
Conflict of interest: none declared.
Similar articles
-
Patient predictors of substance use disorder treatment initiation in primary care.J Subst Abuse Treat. 2018 Jul;90:64-72. doi: 10.1016/j.jsat.2018.04.004. Epub 2018 Apr 28. J Subst Abuse Treat. 2018. PMID: 29866385 Free PMC article. Clinical Trial.
-
The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder.J Gen Intern Med. 2019 Jun;34(6):936-943. doi: 10.1007/s11606-019-04943-6. Epub 2019 Mar 18. J Gen Intern Med. 2019. PMID: 30887440 Free PMC article.
-
Prevalence and treatment of opioid use disorders among primary care patients in six health systems.Drug Alcohol Depend. 2020 Feb 1;207:107732. doi: 10.1016/j.drugalcdep.2019.107732. Epub 2019 Nov 15. Drug Alcohol Depend. 2020. PMID: 31835068 Free PMC article. Clinical Trial.
-
Effects of medication assisted treatment (MAT) for opioid use disorder on functional outcomes: A systematic review.J Subst Abuse Treat. 2018 Jun;89:28-51. doi: 10.1016/j.jsat.2018.03.001. Epub 2018 Mar 13. J Subst Abuse Treat. 2018. PMID: 29706172
-
Medication-Assisted Treatment Considerations for Women with Opiate Addiction Disorders.Prim Care. 2018 Dec;45(4):731-742. doi: 10.1016/j.pop.2018.08.002. Epub 2018 Oct 5. Prim Care. 2018. PMID: 30401353 Review.
Cited by
-
Racial/ethnic disparities in timely receipt of buprenorphine among Medicare disability beneficiaries.Drug Alcohol Depend. 2023 Nov 1;252:110963. doi: 10.1016/j.drugalcdep.2023.110963. Epub 2023 Sep 14. Drug Alcohol Depend. 2023. PMID: 37748421 Free PMC article.
-
Community-, network-, and individual-level predictors of uptake of medication for opioid use disorder among young people who inject drugs and their networks: A multilevel analysis.Drug Alcohol Depend. 2023 Mar 1;244:109782. doi: 10.1016/j.drugalcdep.2023.109782. Epub 2023 Jan 20. Drug Alcohol Depend. 2023. PMID: 36738633 Free PMC article.
-
Impact of an opioid use disorder medication implementation intervention on hospitalization and emergency department utilization in the Veterans Health Administration.BMC Psychiatry. 2025 Mar 26;25(1):288. doi: 10.1186/s12888-025-06722-6. BMC Psychiatry. 2025. PMID: 40140748 Free PMC article.
-
Tailoring services in opioid treatment programs for patients involved in America's criminal justice system: national associations and variation by state and Medicaid expansion status.Subst Abuse Treat Prev Policy. 2021 Jun 19;16(1):50. doi: 10.1186/s13011-021-00388-5. Subst Abuse Treat Prev Policy. 2021. PMID: 34147098 Free PMC article.
-
Opioid Use Disorder and Assessment of Patient Interactions Among Family Medicine Residents, Medical Students, and Physician Assistant Students.MedEdPORTAL. 2020 Nov 12;16:11012. doi: 10.15766/mep_2374-8265.11012. MedEdPORTAL. 2020. PMID: 33204836 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical